Previous close | 5.60 |
Open | 5.63 |
Bid | 5.59 x 200 |
Ask | 5.62 x 200 |
Day's range | 5.38 - 5.74 |
52-week range | 2.13 - 7.73 |
Volume | |
Avg. volume | 625,898 |
Market cap | 268.996M |
Beta (5Y monthly) | 1.31 |
PE ratio (TTM) | 12.40 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Puma Biotechnology (PBYI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
The FDA removes the clinical hold on Iovance's (IOVA) mid-stage study on LN-145 in certain NSCLC patients after reviewing the company's proposal for additional safety measures and monitoring.